105 related articles for article (PubMed ID: 31357239)
1. Analysis of TP53 gene in uterine myomas: No mutations but P72R polymorphism is associated with myoma development.
Altinkaya SO; Avcioglu SN; Sezer SD; Ceylaner S
J Obstet Gynaecol Res; 2019 Oct; 45(10):2088-2094. PubMed ID: 31357239
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism of the p53 tumor suppressor gene is associated with susceptibility to uterine leiomyoma.
Denschlag D; Bettendorf H; Watermann D; Keck C; Tempfer C; Pietrowski D
Fertil Steril; 2005 Jul; 84(1):162-6. PubMed ID: 16009172
[TBL] [Abstract][Full Text] [Related]
3. Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays.
Yatsenko SA; Mittal P; Wood-Trageser MA; Jones MW; Surti U; Edwards RP; Sood AK; Rajkovic A
Fertil Steril; 2017 Feb; 107(2):457-466.e9. PubMed ID: 27889101
[TBL] [Abstract][Full Text] [Related]
4. G-protein-coupled estrogen receptor-30 gene polymorphisms are associated with uterine leiomyoma risk.
Kasap B; Öztürk Turhan N; Edgünlü T; Duran M; Akbaba E; Öner G
Bosn J Basic Med Sci; 2016 Jan; 16(1):39-45. PubMed ID: 26773178
[TBL] [Abstract][Full Text] [Related]
5. Exomic landscape of MED12 mutation-negative and -positive uterine leiomyomas.
Mäkinen N; Vahteristo P; Bützow R; Sjöberg J; Aaltonen LA
Int J Cancer; 2014 Feb; 134(4):1008-12. PubMed ID: 23913526
[TBL] [Abstract][Full Text] [Related]
6. A variant of TP53 gene (rs 1625895, 13494g>A) is associated with neoplasm localization in patients with uterine leiomyoma.
Kornatska AG; Flaksemberg МА; Chubei GV; Trokhymovych ОV; Rossokha ZI; Fishchuk LY; Medvedieva NL; Vershyhora VO; Gorovenko NG
Exp Oncol; 2021 Jun; 43(2):155-158. PubMed ID: 34190520
[TBL] [Abstract][Full Text] [Related]
7. Mutation analysis of CDP, TP53, and KRAS in uterine leiomyomas.
Patrikis MI; Bryan EJ; Thomas NA; Rice GE; Quinn MA; Baker MS; Campbell IG
Mol Carcinog; 2003 Jun; 37(2):61-4. PubMed ID: 12766905
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha-308 promoter and p53 codon 72 gene polymorphisms in women with leiomyomas.
Hsieh YY; Chang CC; Tsai FJ; Lin CC; Yeh LS; Tsai CH
Fertil Steril; 2004 Oct; 82 Suppl 3():1177-81. PubMed ID: 15474092
[TBL] [Abstract][Full Text] [Related]
9. Impact of null genotypes of GSTT1 and GSTM1 with uterine leiomyoma risk in Iranian population.
Mostafavi SS; Ebrahimi A; Sadat SM; Davari Tanha F; Aghasadeghi MR; Bahramali G; Abbasi Ranjbar P; Sadeghifard V; Javadi F
J Obstet Gynaecol Res; 2016 Apr; 42(4):434-9. PubMed ID: 26785830
[TBL] [Abstract][Full Text] [Related]
10. The role of epidermal growth factor receptor (EGFR) common gene mutations in Iranian women with uterine fibroids.
Nikpey P; Nazari T; Khalili S; Ebrahimi A
Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():103-107. PubMed ID: 30149365
[TBL] [Abstract][Full Text] [Related]
11. Uterine leiomyoma is associated with a polymorphism in the interleukin 1-beta gene.
Pietrowski D; Thewes R; Sator M; Denschlag D; Keck C; Tempfer C
Am J Reprod Immunol; 2009 Aug; 62(2):112-7. PubMed ID: 19614627
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of p53 promoter and susceptibility to uterine leiomyoma.
Ziaei E; Chaleshtori MH; Ziaei A; Dehkordi GB; Pooryamofrad A; Kashani S; Batenipoor M; Miraj S
Clin Exp Obstet Gynecol; 2016; 43(5):713-717. PubMed ID: 30074324
[TBL] [Abstract][Full Text] [Related]
13. No association between estrogen receptor beta polymorphisms and uterine leiomyoma.
Zhai XD; Ye Y; Yang Y; Wang Z; Mo YN
DNA Cell Biol; 2009 Dec; 28(12):633-6. PubMed ID: 19715484
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in XPC Gene and Risk of Uterine Leiomyoma in Reproductive Women.
Liu ZQ; Lu MY; Liu B
Pathol Oncol Res; 2020 Jul; 26(3):1459-1464. PubMed ID: 31428994
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in genes HSD17B1 and HSD17B2 and uterine leiomyoma risk in Chinese women.
Cong RJ; Huang ZY; Cong L; Ye Y; Wang Z; Zha L; Cao LP; Su XW; Yan J; Li YB
Arch Gynecol Obstet; 2012 Sep; 286(3):701-5. PubMed ID: 22546946
[TBL] [Abstract][Full Text] [Related]
16. Catechol-O-methyltransferase Val158Met polymorphism is associated with increased risk of multiple uterine leiomyomas either positive or negative for
Dzhemlikhanova LK; Efimova OA; Osinovskaya NS; Parfenyev SE; Niauri DA; Sultanov IY; Malysheva OV; Pendina AA; Shved NY; Ivashchenko TE; Yarmolinskaya MI; Kakhiani MI; Gorovaya EA; Tkachenko AN; Baranov VS
J Clin Pathol; 2017 Mar; 70(3):233-236. PubMed ID: 27491313
[TBL] [Abstract][Full Text] [Related]
17. The CYP17 MspA1 polymorphism is not associated with an increased risk of uterine leiomyomas in a Japanese population.
Tsujino T; Ohara N; Yoshida S; Kennedy S; Takemura N; Deguchi M; Maruo T
Gynecol Endocrinol; 2006 Feb; 22(2):87-91. PubMed ID: 16603433
[TBL] [Abstract][Full Text] [Related]
18. The study of MED12 gene mutations in uterine leiomyomas from Iranian patients.
Sadeghi S; Khorrami M; Amin-Beidokhti M; Abbasi M; Kamalian Z; Irani S; Omrani M; Azmoodeh O; Mirfakhraie R
Tumour Biol; 2016 Feb; 37(2):1567-71. PubMed ID: 26298726
[TBL] [Abstract][Full Text] [Related]
19. PROGINS Polymorphism of the Progesterone Receptor Gene and the Susceptibility to Uterine Leiomyomas: A Systematic Review and Meta-Analysis.
da Silva F; Pabalan N; Ekaratcharoenchai N; Serpa Neto A; Christofolini DM; de Oliveira R; Bianco B; Barbosa CP
Genet Test Mol Biomarkers; 2018 May; 22(5):295-301. PubMed ID: 29630404
[TBL] [Abstract][Full Text] [Related]
20. The effects of p21 gene C98A polymorphism on development of uterine leiomyoma in southeast Iranian women.
Salimi S; Hajizadeh A; Yaghmaei M; Rezaie S; Shahrakypour M; Teimoori B; Parache M; Naghavi A; Mokhtari M
Tumour Biol; 2016 Sep; 37(9):12497-12502. PubMed ID: 27337955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
